🔎 Trials Near Me

Akèy › Kansè po › New York › New York City

Etid klinik pou Kansè po nan New York City, NY

7 etid pou Kansè po ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering (Melanoma/NSCLC), New York
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06060613

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Ap rekriteFaz 3
  • Memorial Sloan Kettering Cancer Center, New York
  • Columbia University Medical Center - Herbert Irving Center for Dermatology and Skin Cancer - Herbert Irving Pavilion, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06585410

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Ap rekriteFaz 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT05859074

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Ap rekriteFaz 1/2
  • Weill Medical College of Cornell University, New York
  • Memorial Sloan Kettering Cancer Center, New York
Laj 18 a 70 · Tout sèks · Mizajou Jun 11, 2026 · NCT05361174

Brodalumab in the Treatment of Immune-Related Adverse Events

Ap rekriteFaz 1
  • Columbia University Irving Medical Center, New York
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06673329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, New York
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Ap rekriteFaz 1/2
  • Bruce Robinson, MD, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2025 · NCT07010692

Etid Kansè po nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.